Cellosaurus cell line CUTO-37 ROS1 p.L2026M (CVCL

Entry history
Cell line name	CUTO-37 ROS1 p.L2026M
Accession	CVCL_E6JB
Resource Identification Initiative	To cite this cell line use: CUTO-37 ROS1 p.L2026M (RRID:CVCL_E6JB)
Comments	Characteristics: Does not show resistance to the five compounds tested (ceritinib, crizotinib, entrectinib, lorlatinib and repotrectinib) (DOI=10.63028/10067/2105480151162165141).
Sequence variations	Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (from parent cell line). Mutation; HGNC; HGNC:10261; ROS1; Simple_edited; p.Leu2026Met (c.6076C>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (DOI=10.63028/10067/2105480151162165141).
Disease	Lung adenocarcinoma (NCIt: C3512)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy	Parent: CVCL_C8T3 (CUTO-37)
Category	Cancer cell line
Publications	DOI=10.63028/10067/2105480151162165141 Terrones M. Profiling targeted therapy responses in ROS1+ non-small cell lung cancer using genomically engineered patient-derived cell lines. Thesis PhD (2024); University of Antwerp; Antwerp; Belgium
Entry creation	10-Apr-2025
Last entry update	10-Apr-2025
Version number	1